Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesClinical/Medical PolicyWPS Hyperbaric Oxygen Coverage Update | OpenPayer
    Ask Trek AI about this page
    CurrentWPS Health InsurancePolicy PUM 250-0017

    Hyperbaric Oxygen Therapy Medical Guideline

    Customize your policy alerts

    Sign up for WPS Health Insurance Policy PUM 250-0017 alerts

    Get alerted when Policy PUM 250-0017 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This guideline governs medical necessity and coverage criteria for systemic or large-chamber hyperbaric oxygen therapy, including covered indications, documentation, treatment-duration limits, and experimental or investigational uses. Providers must apply the criteria together with the member’s benefit plan, applicable law, and current clinical references.

    Policy Summary
    PayerWPS Health Insurance
    PolicyHyperbaric Oxygen Therapy Medical Guideline
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJul 1, 2026
    Next Review DateN/A
    Key ActionReview the member’s health plan and endorsements for applicable exclusions, prior-authorization requirements, and benefit requirements before services are provided.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    21Listed coverage indication categories
    30 daysMaximum initial approval period
    30 daysMinimum standard wound-therapy trial
    Wagner Grade 3+Required wound severity

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    50
    Conditions listed as investigational

    Medical Necessity and Coverage Criteria

    Indications of Coverage

    Systemic or large-chamber hyperbaric oxygen therapy is considered medically necessary when at least ONE of the following indications is documented, including all applicable subcriteria.

    ONE of the following indications

    • Actinomycosis or actinomycotic brain abscess, when hyperbaric oxygen therapy is used with conventional therapy for disease that has not improved with antibiotics or surgery.
    • Acute carbon monoxide intoxication or poisoning.
    • Acute central retinal artery occlusion.
    • Acute peripheral arterial insufficiency.
    • Acute thermal burn injury.
    • Acute traumatic peripheral ischemia threatening loss of limb function, loss of the limb, or loss of life, such as a crush injury or compartment syndrome.
    • Emergent anemia

      • The patient is unable or unwilling to receive red blood cell transfusion.
      • ONE or more of the following

        • Active hemolysis with rapidly progressive anemia.
        • Active massive hemorrhage.
        • Severe signs or symptoms that have not improved with volume replacement, such as tachycardia, hypotension, chest pain, or cognitive impairment.
    • Chronic refractory osteomyelitis that has not responded to conventional medical and surgical treatment.
    • Compartment syndrome.
    • Cyanide poisoning.
    • Decompression sickness.
    • Gas embolism.
    • Gas gangrene.
    • Idiopathic sudden sensorineural hearing loss (ISSHL)

      • ISSHL is treated as an adjunct to systemic steroids.
      • Hearing loss is at least 91 dB over at least three contiguous frequencies and occurred within three days.
      • Treatment is initiated within three months of symptom onset, ideally within two weeks.
    • Intracranial abscess

      • At least ONE characteristic

        • Multiple abscesses.
        • Deep or dominant abscess location.
        • Immunocompromised host.
        • Contraindication to surgery or poor surgical candidate.
      • No clinical response or continued deterioration after surgical intervention, consisting of one to two needle aspirates, and antibiotic therapy.
    • Osteoradionecrosis, when hyperbaric oxygen therapy is used with conventional treatment.
    • Progressive necrotizing infection, including necrotizing fasciitis.
    • Radiation-induced condition

      • Enteritis or proctitis.
      • Hemorrhagic cystitis.
      • Soft-tissue and bone injury of the head and neck, when hyperbaric oxygen therapy is used with conventional treatment.
      • Osteonecrosis before and after extraction of a tooth in an irradiated field.
    • Preparation and preservation of a compromised skin graft or flap in which hypoxia or decreased perfusion has acutely compromised viability.
    • Treatment of crush injuries or severed limbs.
    • Diabetic wound of the lower extremity

      • The patient has type I or type II diabetes and a lower-extremity wound due to diabetes.
      • The wound has shown no improvement after a minimum 30-day trial of standard wound therapy, including correction of vascular conditions in the affected limb where possible; optimization of nutritional status and glucose control; debridement by any means to remove devitalized tissue; maintenance of a clean, moist bed of granulation tissue with appropriate moist dressings; appropriate off-loading; and necessary treatment to resolve any infection.
      • Hyperbaric oxygen therapy is used in conjunction with standard wound care.
      • Wagner Grade 3 or higher

        • Grade 3: deep ulcer with abscess or osteomyelitis.
        • Grade 4: gangrene involving part of the forefoot.

    Topical oxygen therapy (TOT) of any type, including continuous topical oxygen therapy (CTOT) and hyperbaric topical oxygen therapy (HTOT), is experimental, investigational, and unproven to affect health outcomes because insufficient peer-reviewed scientific literature supports its effectiveness.

    Limb-encasing hyperbaric oxygen devices are experimental, investigational, and unproven to affect health outcomes.

    Low-pressure fabric hyperbaric chambers are experimental, investigational, and unproven to affect health outcomes when used for any diagnosis or condition other than acute altitude (mountain) sickness. These devices are FDA-approved only for acute altitude (mountain) sickness and only when compressed with air.

    Hyperbaric oxygen therapy for preparation or preservation of compromised skin grafts or flaps is limited to grafts or flaps whose viability has been acutely compromised by hypoxia or decreased perfusion. It is not covered for primary management of wounds, maintenance of split-thickness grafts, or artificial skin substitutes.

    When hyperbaric oxygen therapy is requested or used for a condition or diagnosis listed in the Indications of Coverage but the applicable criteria are not met, it is considered not medically necessary.

    Clinical Thresholds and Coding Reference

    Idiopathic sudden sensorineural hearing loss
    Hearing-loss thresholdAt least 91 dB over at least three contiguous frequencies
    Onset timingHearing loss occurring within three days
    HBOT initiation windowInitiated within three months of symptom onset, ideally within two weeks
    Diabetic wound standard-therapy trial
    Minimum trial duration30 days of standard wound therapy
    Required responseThe wound must show no improvement after the trial
    Applicable condition

    Authorization, Documentation, and Denial Risks

    Prior Authorization

    Verify Plan Requirements

    Review the member’s benefit plan and endorsements before requesting treatment. Confirm applicable exclusions, prior-authorization requirements, and benefit requirements because plan terms govern coverage.

    Prior Authorization

    Initial Approval Limited to 30 Days

    If coverage criteria are met, initial treatment approval may be granted for a maximum of 30 days from the start of treatment. Inpatient treatment days are included in this 30-day maximum.

    Prior Authorization

    Request Additional Treatment Approval

    Additional treatment requires documentation that the prior treatment period was effective and a physician rationale supporting continued treatment.

    Therapy Overview

    Hyperbaric oxygen therapy delivers high concentrations of oxygen to body tissues and is used for conditions that may respond to increased tissue oxygenation. It may support healing when baseline tissue oxygen levels are too low for spontaneous healing. The guideline recognizes HBOT as primary treatment for some conditions and adjunctive treatment for others; treatment frequency and total duration vary by condition and severity.

    Terms and Severity Classifications

    Hyperbaric oxygen therapy
    TherapyA therapy that delivers high concentrations of oxygen to body tissues
    PurposeUsed for conditions that may respond to increased tissue oxygenation
    Clinical roleMay be primary treatment for some conditions and adjunctive therapy for others
    Wagner Grade 3
    ClassificationWagner Grade 3 diabetic wound
    Wound descriptionDeep ulcer with abscess or osteomyelitis
    Coverage significance
    Policy Summary
    PayerWPS Health Insurance
    PolicyHyperbaric Oxygen Therapy Medical Guideline
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJul 1, 2026
    Next Review DateN/A
    Key ActionReview the member’s health plan and endorsements for applicable exclusions, prior-authorization requirements, and benefit requirements before services are provided.
    SourceLink
    On This Page
    Medical Necessity and Coverage CriteriaClinical Thresholds and Coding ReferenceAuthorization, Documentation, and Denial RisksTherapy OverviewTerms and Severity Classifications
    Grade 5: extensive gangrene of the foot.
    Diabetic lower-extremity wound
    Diabetic wound severity
    Required Wagner gradeGrade 3 or higher
    Minimum qualifying gradeWagner Grade 3
    Covered severity rangeWagner Grades 3, 4, or 5
    Initial treatment approval
    Maximum approval periodUp to 30 days from the start of treatment
    Inpatient treatment daysIncluded in the 30-day maximum
    Approval conditionApplies when the coverage criteria are met
    Documentation Required

    Document Failed Standard Wound Therapy

    For qualifying diabetic lower-extremity wounds, document an unsuccessful minimum 30-day trial of standard wound therapy before requesting hyperbaric oxygen therapy.

    • The trial must include, as applicable, correction of vascular conditions, nutritional and glucose optimization, debridement, a clean moist granulation bed with appropriate dressings, off-loading, and treatment of infection.
    Prior Authorization

    Continue Standard Wound Care Concurrently

    Use hyperbaric oxygen therapy in conjunction with standard wound care for qualifying diabetic lower-extremity wounds; it is not a substitute for required wound-care measures.

    • The wound must be due to type I or type II diabetes.
    • The wound must be classified as Wagner Grade 3 or higher.

    Unsupported block type: documentation

    Documentation Required

    Provide Medical Records and Wound Measurements

    Provide medical records supporting medical necessity and continued need or use when applicable, including the required wound-treatment measurements.

    • Include serial ruler measurements or photographic measurements for wound treatment.
    Documentation Required

    Document Effectiveness for Continued Treatment

    For continuation treatment, submit serial ruler measurements or photographs showing the wound’s response to the previous treatment period, along with physician documentation supporting continued treatment.

    • Provide a physician progress note for each date of service on which the physician was present during treatment.
    • Show evidence that the previous month’s treatments were effective.
    Billing Rule

    Use Correct Coding

    Use correct coding for the item or service and comply with all applicable coding guidelines.

    Denial Risk

    Unlisted Conditions Are Unproven

    If treatment is requested or used for a condition or diagnosis not listed in the indications of coverage, it is considered experimental, investigational, and unproven to affect health outcomes.

    Denial Risk

    Criteria Not Met

    A listed condition is not medically necessary when the applicable indication or coverage criteria are not met.

    • Do not assume that a diagnosis listed in the indications of coverage is sufficient by itself; all applicable criteria must be satisfied.
    Denial Risk

    Experimental or Investigational Uses

    The following uses are considered experimental, investigational, and unproven to affect health outcomes and are not medically necessary under the guideline.

    • Topical oxygen therapy of any type, including continuous and hyperbaric topical oxygen therapy.
    • Limb-encasing hyperbaric oxygen devices.
    • Low-pressure fabric hyperbaric chambers for any diagnosis other than acute altitude sickness; these devices are FDA-approved only for acute altitude sickness when compressed with air.
    • Hyperbaric oxygen therapy for the listed investigational conditions, including conditions such as arterial, cutaneous, decubitus, stasis, and venous ulcers; chronic peripheral vascular insufficiency; fracture healing; frostbite; traumatic brain injury or post-concussive syndrome; and other conditions identified in the guideline.
    Denial Risk

    Diabetic Wound Criteria Must Be Met

    Requests for diabetic lower-extremity wounds are at risk of denial when required criteria are absent or not documented.

    • No type I or type II diabetes or no documented wound due to diabetes.
    • No documented failure to improve after the minimum 30-day standard wound-therapy trial.
    • Wound is not Wagner Grade 3 or higher.
    • Hyperbaric oxygen therapy is not used with standard wound care.
    • Required vascular, nutritional, glucose-control, debridement, dressing, off-loading, or infection-treatment measures are absent or undocumented.
    Denial Risk

    Avoid Denial for Insufficient Continuation Documentation

    Continued treatment is not supported by approval of the initial period alone. Additional treatment requires evidence that prior treatment was effective and appropriate physician documentation for the continued course.

    • Provide serial ruler measurements or photographs demonstrating effectiveness of the previous month’s treatments.
    • Provide a physician progress note for each date of service on which the physician was present during treatment.
    • Document the ongoing medical necessity and continued need or use when applicable.
    Meets the minimum Wagner severity threshold when the other diabetic-wound requirements are satisfied
    Wagner Grade 4
    ClassificationWagner Grade 4 diabetic wound
    Wound descriptionGangrene involving a portion of the forefoot
    Coverage significanceMeets the Wagner Grade 3-or-higher severity threshold when the other diabetic-wound requirements are satisfied
    Wagner Grade 5
    ClassificationWagner Grade 5 diabetic wound
    Wound descriptionExtensive gangrene of the foot
    Coverage significanceMeets the Wagner Grade 3-or-higher severity threshold when the other diabetic-wound requirements are satisfied
    Topical oxygen therapy
    Umbrella termTopical oxygen therapy (TOT)
    Continuous topical oxygen therapyCTOT
    Hyperbaric topical oxygen therapyHTOT